You are here: Industry Insights > DTC

News List

DTC genetic testing market size to exceed $2.5bn by 2025 biospectrumasia
July 10, 2019
According to a new research report by Global Market Insights, DTC Genetic Testing Market size is set to exceed USD 2.5 billion by 2025
West Opens Digital Technology Center pharmafocusasia
March 14, 2019
The 17,000 square foot center is located in the heart of Bengaluru, India's Outer Ring Road (ORR) technology district.
Doctors’ advice for pharma in 2019? Lay off DTC and ramp up generics: study fiercepharma
February 24, 2019
Doctors think pharma should go on a DTC diet. When asked what pharma companies can do in 2019 to reduce drug prices, more than half (52%) said pharma should spend less money on DTC advertising and marketing, healthcare market researcher InCrowd found in i
Researchers find new mechanism to control spread of breast cancer pharmaceutical-technology
January 23, 2019
Researchers at the Fred Hutchinson Cancer Research Center in Seattle, the US, have discovered how cells that have broken away from breast cancer tumours evaded chemotherapy and ....
Medical marketing spend is inching toward $30B, and DTC's share is growing fiercepharma
January 13, 2019
It’s no surprise that medical marketing spending has skyrocketed in the past 20 years. And while marketing to physicians continues to consume the lion's share of the almost $30 billion spent overall, direct-to-consumer marketing is catching up.
Easy as 1-2-3, GSK’s triple COPD drug Trelegy dances onto TV with first DTC ads fiercepharma
September 27, 2018
GlaxoSmithKline is spinning the first DTC campaign this week for its crucial new COPD drug, Trelegy Ellipta, backed by a throwback soundtrack. The theme song reworks The Jackson 5’s hit tune “ABC," focusing on the ...
Endo, building on DTC success, ramps up awareness campaign for Peyronie’s disease fiercepharma
August 23, 2018
Endo Pharmaceuticals is continuing its awareness advertising push around conditions that can be treated with its injectable Xiaflex. (Pixabay/CC BY 2.0)
Flexion CEO says its Zilretta representatives will rev up the launch—and DTC ads will help, too fiercepharma
May 03, 2018
Zilretta has several things going for it. It’s not an opioid painkiller—a plus at a time when opioid addiction is a nationwide issue.
Where could Allergan’s cost cuts fall? DTC spending, for starters fiercepharma
November 03, 2017
Allergan’s investment level over the past year and a half or so has been “fairly high,” thanks to a dozen new products or indications.
FDA Allows Marketing of First Direct-to-Consumer Tests that Provide Genetic Risk Information for Cer drugs.com
April 07, 2017
The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions.